Navigation Links
Solta Medical Provides Update on Liposonix Launch
Date:3/7/2012

HAYWARD, Calif., March 7, 2012 /PRNewswire/ -- Solta Medical, Inc. (NASDAQ: SLTM), a global leader in the medical aesthetics market, today provided an update on the launch of the second generation Liposonix non-invasive fat reduction system recently approved by the FDA.

A majority of the Company's approximately twenty key opinion leaders (KOLs), comprised of leading plastic surgeons and dermatologists, who received Liposonix systems in mid-December as part of the pre-launch trial, have successfully evaluated and purchased the product. The company expects that virtually all the remaining KOL's evaluating the system will purchase the device this month. Liposonix was officially introduced in early January of 2012.

"For the full year 2012, we provided guidance that we would generate approximately $17 million in Liposonix revenue," said Stephen J. Fanning, Chairman, President and CEO of Solta Medical.  "Through the first two months of the year, we are on track to meet or exceed this guidance. Systems have been sold, on average, at list price."

The Liposonix system uses non-invasive, high-intensity focused ultrasound (or HIFU) to permanently get rid of targeted fat around the waistline, love handles and abdomen, without surgery. The average waistline reduction after just one, 1-hour treatment is about one inch – which typically means one dress or pant size. Results are usually seen in 8 to 12 weeks (which is the time needed for the body to naturally remove the treated fat).

Since its introduction, Liposonix has been featured in many high profile media outlets, including national broadcast programs such as Dr. Oz, The Doctors, and 20/20 with Barbara Walters. Thus far the Liposonix treatment has received very positive reviews from patients as reflected in on-line aesthetic procedure forums.

"The Gen 2 system is proving to provide several distinct advantages compared with the first generation, including a larger treatment tip, which enables clinicians to deliver comparable energy over multiple passes while maintaining a treatment time of about an hour," continued Mr. Fanning.  "This has improved the treatment experience for both patients and physicians."

"In addition, most physicians using Liposonix do not find it necessary to medicate patients for the treatment, and those that do, are using non-narcotic medication, resulting in little to no post-treatment downtime.  The acceptance and feedback from physicians about our Gen 2 system has been extremely positive and Liposonix is delivering on its promise of one treatment, one hour, one inch or pant size smaller," Mr. Fanning concluded. 

The Company will be exhibiting Liposonix along with all of its industry leading aesthetic solutions at the American Academy of Dermatology meeting from March 17 to 19 at the San Diego Convention Center (Booth #1211).

About Solta Medical, Inc.

Solta Medical, Inc. is a global leader in the medical aesthetics market providing innovative, safe, and effective solutions for patients that enhance and expand the practice of medical aesthetics for physicians. The company offers products to address a range of skin issues under the industry´s six premier brands: Thermage®, Fraxel®, Liposonix®, Isolaz®, CLARO® and Clear + Brilliant®. Thermage is an innovative, non-invasive radiofrequency procedure for tightening and contouring skin. As the leader in fractional laser technology, Fraxel delivers minimally invasive clinical solutions to resurface aging and sun damaged skin. The Liposonix system uses advanced high–intensity focused ultrasound (HIFU) technology to permanently destroy targeted fat just beneath the skin in the treatment areas of the abdomen and flanks as a noninvasive, nonsurgical approach to aesthetic waist circumference reduction. Isolaz was the first laser or light based system indicated for the treatment of inflammatory acne, comedonal acne, pustular acne, and mild–to–moderate inflammatory acne. CLARO is a personal care acne system that is the first FDA cleared over–the–counter IPL device that uses a powerful combination of both heat and light to clear skin quickly and naturally. Clear + Brilliant is a unique, cost–effective treatment that utilizes safe, fractional laser technology to correct and prevent early signs of aging and is FDA cleared and CE marked. Since 2002, over one million Thermage, Fraxel and Isolaz procedures have been performed in over 100 countries. For more information about Solta Medical, call 1-877-782-2286 or log on to www.Solta.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, including statements regarding expected future purchases of Liposonix systems and anticipated revenue. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks and uncertainties, which may cause Solta Medical's actual results to differ materially from the statements contained herein. Factors that might cause such a difference include the risk that physician adoption of our systems does not grow, the risk that customers do not continue to purchase treatment tips, the possibility that the market for the sale of new products does not develop as expected, and the risks relating to Solta Medical's ability to achieve its stated financial goals as a result of, among other things, economic conditions and consumer and physician confidence causing changes in consumer and physician spending habits that affect demand for our products and treatments. Further information on potential risk factors that could affect Solta Medical's business and its financial results are detailed in its Form 10-Q for the quarter ended September 30, 2011, and other reports as filed from time to time with the Securities and Exchange Commission. Undue reliance should not be placed on forward-looking statements, especially guidance on future financial performance, which speaks only as of the date they are made. Solta Medical undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date they were made, or to reflect the occurrence of unanticipated events.


'/>"/>
SOURCE Solta Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Solta Medical Announces FDA 510(k) Clearance of New Fraxel re:store(R) Dual Laser System
2. Solta Medical Donates Fraxel re:store(R) Laser System to Grossman Burn Foundation
3. Solta Medical Announces New Fraxel re:store(R) Dual Laser System, Receives CE Mark for European Market
4. Solta Medical, Inc. Announces Fourth Quarter 2009 Results Release Date and Conference Call
5. Solta Medical to Participate in 2nd Annual Lazard Capital Markets Medical Technology Conference
6. Solta Medical and Alma Lasers Resolve Patent Lawsuits
7. Solta Medical Receives Provectus Innovation Award at MDB Capital Groups Bright Lights Intellectual Property Conference
8. Solta Medical Announces Thermage CPT™ and Fraxel re:store® Dual Systems Receive Health Canada Approval
9. Solta Medical, Inc. Announces Second Quarter 2010 Results Release Date and Conference Call
10. Len DeBenedictis Retires as Chief Technology Officer of Solta Medical, Inc.
11. Solta Medical Announces FDA 510(k) Clearance of Fraxel re:store Dual Laser System for the Treatment of Actinic Keratosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)...  Patients in Alabama seeking prostate ... no longer have to travel out of state. Vituro ... Urology Centers of Alabama to provide a total prostate ... patients. Alabama is known ... prostate cancer using many different modalities. They are the largest ...
(Date:2/5/2016)...  Venice,s newest laser clinic, Physicians Advanced ... kind in the area and specializes in the ... The physician-owned and operated laser clinic is taking ... with its revitalizing skin care approach, unprecedented eVisit ... technology. http://photos.prnewswire.com/prnh/20160204/329957 --> ...
(Date:2/5/2016)... --> --> ... (Labor & Delivery) and Neonatal Care Equipment Market Ultrasound, ... Phototherapy/Jaundice Management Devices, CPAP, Capnograph, & Resuscitator) - Global ... the global market over the forecast period of 2015 ... Billion in 2015 and is poised to grow at ...
Breaking Medicine Technology:
(Date:2/8/2016)... Washington, D.C. (PRWEB) , ... February 08, 2016 ... ... has officially launched its newly redesigned website, federallabs.org . The site houses ... technologies or license available federal technologies through the process called technology transfer (T2). ...
(Date:2/8/2016)... Houma, LA (PRWEB) , ... February 08, 2016 ... ... Louisiana from offices in Houma, LA, celebrates the beginning of a new charity ... raised to assist Court Appointed Special Advocates (CASA). In the belief that children ...
(Date:2/8/2016)... ... February 08, 2016 , ... Brenton Engineering , ... bags, and flow wrapped products at WestPack 2015, February 9-11, in Anaheim, California. ... up to semi-automatic or fully-automatic case packing with a small footprint, rugged, highly ...
(Date:2/8/2016)... ... February 08, 2016 , ... Steve Helwig & Associates Insurance ... new community enrichment program, has teamed up with Citizens Opposed to Domestic Abuse in ... intimate abuse. To support all those victimized by the fear of violence in their ...
(Date:2/8/2016)... ... February 08, 2016 , ... Delta Dental of California and its affiliated ... , Gary D. Radine, who recently retired as president and CEO of Delta Dental ... 2015 CEO of the Year , helped lead the effort to raise funds for ...
Breaking Medicine News(10 mins):